JPMorgan Chase Has Raised Its Dividend for 14 Years Running. Is It the Best Dividend Stock in Banking?

JPMorgan Chase posted strong first-quarter results, with revenue up 13% year over year and EPS up 17%, while also lifting its dividend again in 2025 for a cumulative 20% increase this year. The article argues the stock may be expensive at 2.3x price-to-book versus its five-year average of about 1.8x and offers only a 2% yield versus a 2.3% bank average. Bank of Nova Scotia is presented as the higher-yield alternative at 4.1% for income-focused investors.

Analysis

The market is rewarding JPM as a high-quality compounder, but the setup is increasingly a duration trade on safety rather than a pure earnings trade. At 2.3x book and a sub-2.5% yield, investors are effectively paying up for a perceived “no-drama” franchise while missing that the upside from further multiple expansion is limited unless rates stay supportive and credit remains benign. That makes JPM more vulnerable to a mild rerating than the headline fundamentals suggest: in a risk-off tape, its relative outperformance can persist, but in a stable-to-bullish bank tape, cheaper balance-sheet names should catch up faster.

The bigger second-order winner is not JPM itself but the higher-yielding deposit-rich banks that have not re-rated as aggressively. BNS screens as the cleaner income alternative: the yield gap versus JPM is wide enough that even modest multiple compression at JPM or multiple expansion at BNS can create a meaningful total-return spread over the next 6-12 months. BAC is a different case — it is the most obvious relative-value beneficiary if the market starts pricing in more normalization in NII and a valuation catch-up, but it still carries more execution risk and a weaker investor trust premium than JPM.

The dividend-streak narrative is a bit of a consensus trap: investors are conflating post-crisis dividend consistency with permanent capital allocation superiority. The more important question is what happens if earnings normalize lower from peak rates; JPM’s payout ratio looks comfortable today, but that comfort is partly propped up by the current rate regime. If cuts in policy rates accelerate over the next 2-4 quarters, the market may stop paying up for the stock unless fee growth and buybacks offset the NII drag.

Catalyst-wise, the next leg matters more than the last quarter: a flattening of loan growth, even without credit deterioration, would compress the premium multiple quickly. The stock is still defensible for low-volatility total return, but the risk/reward now favors rotating part of the exposure into higher-yield peers or expressing the view as a relative-value pair rather than an outright long.

Key Decisions for Investors

• Trim JPM on strength over the next 1-2 weeks if it continues to trade above ~2.2x book; upside from here looks capped unless rates re-accelerate, while downside from any NII deceleration could compress the premium multiple quickly.
• Initiate a 6-12 month long BNS / short JPM pair trade to capture the valuation and yield gap; BNS offers higher carry and more room for multiple convergence if bank sentiment broadens.
• For investors wanting U.S. bank beta, prefer BAC over JPM only as a relative-value trade on a 3-6 month horizon; buy BAC on weakness versus JPM, not as a standalone quality premium name.
• Use JPM as a covered-call candidate: long stock, sell 1-2 month out-of-the-money calls to monetize limited upside and protect against sideways-to-mildly lower valuation drift.
• Monitor for rate-cut repricing; if front-end yields fall 50-75 bps, reassess JPM as a hold rather than an add, since the market will likely refocus on NII compression rather than dividend growth.